tetradecanoylphorbol acetate has been researched along with bufalin in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (75.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Batista-Gonzalez, A; Brunhofer, G; Fallarero, A; Gopi Mohan, C; Karlsson, D; Shinde, P; Vuorela, P | 1 |
| Fujino, E; Inoue, N; Kuroiwa, Y; Nakura, H; Numazawa, S; Shinoki, M; Sugiyama, T; Yoshida, T | 1 |
| Hauck, CR; Lorenzen, D; Meyer, TF; Saas, J | 1 |
| Hashimoto, S; Jing, Y; Kawazoe, N; Kuroiwa, Y; Masuda, Y; Nakajo, S; Nakaya, K; Yoshida, T | 1 |
4 other study(ies) available for tetradecanoylphorbol acetate and bufalin
| Article | Year |
|---|---|
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
Topics: Acetylcholinesterase; Amyloid beta-Peptides; Benzophenanthridines; Binding Sites; Butyrylcholinesterase; Catalytic Domain; Cholinesterase Inhibitors; Humans; Isoquinolines; Kinetics; Molecular Docking Simulation; Structure-Activity Relationship | 2012 |
A cardiotonic steroid bufalin-induced differentiation of THP-1 cells. Involvement of Na+, K(+)-ATPase inhibition in the early changes in proto-oncogene expression.
Topics: Bufanolides; Cardiotonic Agents; Cell Differentiation; Gene Expression Regulation; Humans; Leukemia, Myeloid; Proto-Oncogene Mas; Proto-Oncogene Proteins; Sodium-Potassium-Exchanging ATPase; Tetradecanoylphorbol Acetate; Tumor Cells, Cultured | 1996 |
An in vitro-differentiated human cell line as a model system to study the interaction of Neisseria gonorrhoeae with phagocytic cells.
Topics: Adult; Antibodies, Monoclonal; Antigens, Bacterial; Bufanolides; Cell Differentiation; Cells, Cultured; Cholecalciferol; Flow Cytometry; Fluorescent Antibody Technique, Indirect; Gonorrhea; Granulocyte-Macrophage Colony-Stimulating Factor; Histocompatibility Antigens Class II; HLA-DR Antigens; Humans; Interferon-gamma; Leukocytes, Mononuclear; Monocytes; Neisseria gonorrhoeae; Phagocytosis; Respiratory Burst; Tetradecanoylphorbol Acetate; Tretinoin; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha | 1997 |
Bufalin reduces the level of topoisomerase II in human leukemia cells and affects the cytotoxicity of anticancer drugs.
Topics: Antineoplastic Agents; Apoptosis; Bufanolides; Cisplatin; DNA Fragmentation; DNA Topoisomerases, Type II; DNA, Neoplasm; Drug Synergism; Enzyme Induction; Enzyme Inhibitors; HL-60 Cells; Humans; Isoenzymes; Neoplasm Proteins; RNA, Messenger; RNA, Neoplasm; Tetradecanoylphorbol Acetate; Topoisomerase II Inhibitors; Tretinoin | 1997 |